Stephen J. Kaar

1.7k total citations
31 papers, 1.1k citations indexed

About

Stephen J. Kaar is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Stephen J. Kaar has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Stephen J. Kaar's work include Schizophrenia research and treatment (11 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Stephen J. Kaar is often cited by papers focused on Schizophrenia research and treatment (11 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Stephen J. Kaar collaborates with scholars based in United Kingdom, Italy and United States. Stephen J. Kaar's co-authors include Oliver Howes, Robert A. McCutcheon, Sridhar Natesan, Adam Winstock, Alex J. Mitchell, Tiago Reis Marques, Ilinca Angelescu, Rohan Borschmann, Jason Ferris and Jon Waldron and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Stephen J. Kaar

27 papers receiving 1.1k citations

Peers

Stephen J. Kaar
Stephen J. Kaar
Citations per year, relative to Stephen J. Kaar Stephen J. Kaar (= 1×) peers Manabu Saito

Countries citing papers authored by Stephen J. Kaar

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Kaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Kaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Kaar more than expected).

Fields of papers citing papers by Stephen J. Kaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Kaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Kaar. The network helps show where Stephen J. Kaar may publish in the future.

Co-authorship network of co-authors of Stephen J. Kaar

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Kaar. A scholar is included among the top collaborators of Stephen J. Kaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Kaar. Stephen J. Kaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vano, Luke, Robert A. McCutcheon, Jan Sedlacik, et al.. (2025). Reduced Brain Iron and Striatal Hyperdopaminergia in Schizophrenia: A Quantitative Susceptibility Mapping MRI and PET Study. American Journal of Psychiatry. 182(9). 830–839. 1 indexed citations
4.
O’Donnell, Amy, et al.. (2025). A qualitative exploration of the barriers and facilitators to the implementation of the alcohol assertive outreach model. Alcohol and Alcoholism. 60(2). 1 indexed citations
5.
6.
Dhanda, Ashwin, James A. King, Fiona C Warren, et al.. (2024). Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review. EClinicalMedicine. 78. 102920–102920. 15 indexed citations
7.
Vano, Luke, Robert A. McCutcheon, Grazia Rutigliano, et al.. (2024). Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-Sensitive Magnetic Resonance Imaging and [18F]-DOPA Positron Emission Tomography Study. Biological Psychiatry. 96(8). 674–683. 5 indexed citations
8.
Arumuham, Atheeshaan, Ekaterina Shatalina, Matthew M. Nour, et al.. (2024). Working memory processes and the histamine-3 receptor in schizophrenia: a [11C]MK-8278 PET-fMRI study. Psychopharmacology. 242(6). 1321–1334.
9.
Howes, Oliver, et al.. (2024). New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction. Biological Psychiatry. 96(8). 638–650. 20 indexed citations
10.
Pillinger, Toby, Faith Borgan, Katherine Beck, et al.. (2022). Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study. The British Journal of Psychiatry. 221(6). 740–747. 17 indexed citations
11.
Kaar, Stephen J., Ilinca Angelescu, Matthew M. Nour, et al.. (2022). The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia. Psychopharmacology. 239(10). 3313–3323. 9 indexed citations
12.
Whitehurst, Thomas, et al.. (2021). New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics. Neuroscience & Biobehavioral Reviews. 132. 324–361. 61 indexed citations
13.
Angelescu, Ilinca, Stefan Brugger, Faith Borgan, Stephen J. Kaar, & Oliver Howes. (2021). The magnitude and variability of brain structural alterations in bipolar disorder: A double meta-analysis of 5534 patients and 6651 healthy controls. Journal of Affective Disorders. 291. 171–176. 16 indexed citations
14.
Beck, Katherine, Atheeshaan Arumuham, Mattia Veronese, et al.. (2021). N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study. Translational Psychiatry. 11(1). 425–425. 15 indexed citations
15.
Kaar, Stephen J., Sridhar Natesan, Robert A. McCutcheon, & Oliver Howes. (2019). Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 172. 107704–107704. 232 indexed citations
16.
Kaar, Stephen J., et al.. (2019). Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid. BMC Psychiatry. 19(1). 309–309. 25 indexed citations
17.
Kaar, Stephen J., Ilinca Angelescu, Tiago Reis Marques, & Oliver Howes. (2019). Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies. Journal of Neural Transmission. 126(12). 1637–1651. 97 indexed citations
18.
Kaar, Stephen J., et al.. (2018). Antipsychotic drugs: challenges and future directions. World Psychiatry. 17(2). 170–171. 16 indexed citations
19.
Kaar, Stephen J.. (2017). Narrative review: The Meaning of “Recovery” for Addiction Treatment and Research. 4. 1–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026